Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard

COLUMBUS, Ohio, Feb. 18, 2025 /PRNewswire/ — Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has expanded its AAV Curator™ Platform offering and License Agreement with the Broad Institute of MIT…